To address the contribution of ANX2 to tumorigenesis Sharma et al. [113] demonstrated that administration of a neutralizing antibody directed against cell-surface associated ANX2 inhibits growth of human breast tumor in a xenograft model and that this effect depends, in part, on the attenuation of the neoangiogenic potential of tumor. The gene discussed is ANXA2; the disease is breast neoplasm.